PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
暂无分享,去创建一个
Guy Bormans | Nick Devoogdt | Tony Lahoutte | Ilse Vaneycken | Anneleen Blykers | Vicky Caveliers | Geert Raes | Catarina Xavier | Patrick De Baetselier | G. Bormans | P. De Baetselier | N. Devoogdt | K. D'hoe | S. Schoonooghe | J. V. Van Ginderachter | V. Caveliers | T. Lahoutte | D. Laoui | G. Raes | C. Xavier | I. Vaneycken | Steve Schoonooghe | Kevin D’hoe | Damya Laoui | Matthias D’Huyvetter | Frederik Cleeren | Johannes Heemskerk | Jo A. Van Ginderachter | Johannes Heemskerk | M. D'Huyvetter | A. Blykers | F. Cleeren | Damya Laoui
[1] N. Devoogdt,et al. Site-specific labeling of his-tagged Nanobodies with ⁹⁹mTc: a practical guide. , 2012, Methods in molecular biology.
[2] A. Wu. Engineered antibodies for molecular imaging of cancer. , 2014, Methods.
[3] A. Luxen,et al. Fully Automated Preparation and Conjugation of N-Succinimidyl 4-[18F]Fluorobenzoate ([18F]SFB) with RGD Peptide Using a GE FASTlab™ Synthesizer , 2011, Molecular Imaging and Biology.
[4] S. Goerdt,et al. Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.
[5] J. Pickard,et al. Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[(18)F]fluorobenzoate and application to (18)F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography. , 2008, Nuclear medicine and biology.
[6] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[7] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[8] Wenbin Zeng,et al. Facile synthesis of N‐succinimidyl 4‐[18F]fluorobenzoate ([18F]SFB) for protein labeling , 2008 .
[9] G. Antoni,et al. Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde. , 2014, Bioconjugate chemistry.
[10] Alexandros Nikolaou,et al. Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. , 2011, Immunobiology.
[11] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.
[12] Eduard Schreibmann,et al. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] Jakub Toczek,et al. Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions , 2012, Circulation research.
[14] A. Wu,et al. ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging , 2012, Tumor Biology.
[15] P. Carmeliet,et al. Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population. , 2014, Cancer research.
[16] A. Scott,et al. A simplified protocol for the automated production of succinimidyl 4‐[18F]fluorobenzoate on an IBA Synthera module , 2011 .
[17] S. Muyldermans,et al. Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target , 2013, Expert opinion on biological therapy.
[18] P. De Baetselier,et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.
[19] Christian Vanhove,et al. Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT , 2008, Journal of Nuclear Medicine.
[20] J. Frère,et al. β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae , 2001, Antimicrobial Agents and Chemotherapy.
[21] P. De Baetselier,et al. Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancer. , 2012, Immunobiology.
[22] S. Muyldermans,et al. Generation of single domain antibody fragments derived from camelids and generation of manifold constructs. , 2012, Methods in molecular biology.
[23] H. VanBrocklin,et al. Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer , 2009, Journal of Nuclear Medicine.
[24] S. Gambhir,et al. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] P. Allavena,et al. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. , 2008, Critical reviews in oncology/hematology.
[26] P. De Baetselier,et al. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. , 2012, Cancer research.
[27] S. Muyldermans,et al. Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types , 2010, Journal of Nuclear Medicine.
[28] Nicholas J Long,et al. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. , 2008, Angewandte Chemie.
[29] Alberto Signore,et al. N-(4-18F-Fluorobenzoyl)Interleukin-2 for PET of Human-Activated T Lymphocytes , 2012, The Journal of Nuclear Medicine.
[30] S. Muyldermans,et al. Naturally occurring antibodies devoid of light chains , 1993, Nature.